Genomic analysis of malaria parasites reveals which genetic variants are most likely to confer resistance to antimalarial ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

Analysing malaria parasite genomes may usher new and more effective treatments for the deadly mosquito-borne disease and also ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

Researchers at UC San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are ...

Researchers have used a new gold-based drug to slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a new study.

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics ...